Shandong Lukang Pharmaceutical Co Ltd (600789) — Capital Reinvestment Ratio
Shandong Lukang Pharmaceutical Co Ltd (600789) has a Capital Reinvestment Ratio of 0.31x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥285.47 Million) in capital expenditures (CN¥88.93 Million). Check Shandong Lukang Pharmaceutical Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Lukang Pharmaceutical Co Ltd Capital Reinvestment Ratio (1998–2025)
This chart tracks Shandong Lukang Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 28 annual periods. For the full cash flow conversion analysis, see Shandong Lukang Pharmaceutical Co Ltd cash conversion from operations.
Annual Capital Reinvestment Ratio for Shandong Lukang Pharmaceutical Co Ltd (1998–2025)
Year-by-year Capital Reinvestment Ratio for Shandong Lukang Pharmaceutical Co Ltd from 1998 to 2025. See 600789 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.49x | CN¥698.17 Million | CN¥338.86 Million | ▼ -30.0% |
| 2024 | 0.69x | CN¥402.82 Million | CN¥279.18 Million | ▲ +23.9% |
| 2023 | 0.56x | CN¥604.01 Million | CN¥337.91 Million | ▼ -42.0% |
| 2022 | 0.96x | CN¥444.38 Million | CN¥428.36 Million | ▼ -70.4% |
| 2021 | 3.26x | CN¥149.33 Million | CN¥486.75 Million | ▲ +8.7% |
| 2020 | 3.00x | CN¥234.55 Million | CN¥703.12 Million | ▲ +30.9% |
| 2019 | 2.29x | CN¥361.87 Million | CN¥828.61 Million | ▼ -6.0% |
| 2018 | 2.44x | CN¥351.09 Million | CN¥855.24 Million | ▼ -14.0% |
| 2017 | 2.83x | CN¥275.51 Million | CN¥780.71 Million | ▲ +125.9% |
| 2016 | 1.25x | CN¥296.23 Million | CN¥371.51 Million | ▼ -40.3% |
| 2015 | 2.10x | CN¥78.39 Million | CN¥164.54 Million | ▲ +93.2% |
| 2014 | 1.09x | CN¥108.56 Million | CN¥117.94 Million | ▲ +21.0% |
| 2013 | 0.90x | CN¥256.50 Million | CN¥230.35 Million | ▼ -63.6% |
| 2012 | 2.47x | CN¥115.20 Million | CN¥284.40 Million | ▼ -29.0% |
| 2011 | 3.48x | CN¥123.28 Million | CN¥428.82 Million | ▲ +269.6% |
| 2010 | 0.94x | CN¥308.88 Million | CN¥290.69 Million | ▲ +169.9% |
| 2009 | 0.35x | CN¥199.49 Million | CN¥69.57 Million | ▼ -4.7% |
| 2008 | 0.37x | CN¥209.39 Million | CN¥76.58 Million | ▲ +116.0% |
| 2007 | 0.17x | CN¥137.30 Million | CN¥23.25 Million | ▼ -56.9% |
| 2006 | 0.39x | CN¥56.24 Million | CN¥22.12 Million | ▲ +3.7% |
| 2005 | 0.38x | CN¥161.64 Million | CN¥61.27 Million | ▼ -82.0% |
| 2004 | 2.10x | CN¥63.24 Million | CN¥133.10 Million | ▲ +96.6% |
| 2003 | 1.07x | CN¥167.42 Million | CN¥179.25 Million | ▲ +69.0% |
| 2002 | 0.63x | CN¥315.59 Million | CN¥199.94 Million | ▼ -15.8% |
| 2001 | 0.75x | CN¥270.43 Million | CN¥203.50 Million | ▼ -93.3% |
| 2000 | 11.21x | CN¥22.36 Million | CN¥250.64 Million | ▲ +312.0% |
| 1999 | 2.72x | CN¥35.12 Million | CN¥95.56 Million | ▼ -20.0% |
| 1998 | 3.40x | CN¥46.18 Million | CN¥156.96 Million | — |